Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years @RheumNow #acr22 #acrreview #osteoporosis
ACR 2022 Tweet by TheDaoIndex
Tweet
Related Content
In a recent JAMA Viewpoints article, Dr. Susan Ott addresses several controversies in preventing osteoporosis (OP) related fractures.
A report in The Lancet Diabetes & Endocrinology suggested that 3 months of romosozumab (ROMO) followed by denosumab is as effective at increasing hip bone mineral density (BMD) as the standard 12-month course.
